Bosques-Padilla FJ, Flores-Rendón AR

Idioma: Español
Referencias bibliográficas: 17
Paginas: 372-374
Archivo PDF: 46.85 Kb.

FRAGMENTO

La encefalopatía hepática (EH) es un desorden de la función del sistema nervioso central, debida fundamentalmente a la presencia de grados variables de insuficiencia hepática, teniendo un gran impacto en la calidad de vida del paciente. Ésta tiene un trasfondo seguramente multifactorial, siendo el amonio, producto derivado principalmente del intestino, un factor importante.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Blei A, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.

2. Groenweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.

3. Weissenborn K, Ennen JC, Schomerus H, Ruckery N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.

4. Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003; 61: 307-13.

5. Bongaerts GPA, Severijnen RSVM. The beneficial antimicrobial effect of probiotics. Med Hypotheses 2001; 56: 174-7.

6. Bongaerts GPA, Severijnen RSVM. New strategies in antimicrobial therapy. Med Hypotheses 2001; 56: 178-80.

7. Vogels GD, Van der Drift C. Degradation of purines and pyrimidines. Bacteriol Rev 1977; 40: 403-68.

8. Bongaerts GPA, Vogels GD. Uric acid degradation by bacillus fastidiosus strains. J Bacteriol 1976; 125: 689-97.

9. Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 2003; 62: 95-9.

10. Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 1999; 129: 1438s-1441s.

11. Kandler O, Weiss N. Regular, nonsporing gram-positive rods. Genus Lactobacillus. In: Sneath PHA (ed.). Bergey’s manual of systematic bacteriology. Vol. 2. Baltimore, USA: Williams&Wilkins; 1986, p. 1209-34.

12. Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9.

13. Solga SF, Diehl AM. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 2004; 39: 1197-200.

14. Vilstrup H. Cirrhosis and bacterial infections. Rom J Gastroenterol 2003; 12: 297-302.

15. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.

16. Fontanarosa P, Rennie D, DeAngelis C. The need for regulation of dietary supplements-lessons from ephedra. JAMA 2003; 289: 1568-70.

17. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002.